Report : North America In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

Reagents and Kits Segment has the Largest Share of Product and Services in the North America In-Vitro Diagnostics Market during 2019–2027

According to a new market research study on “North America In-Vitro Diagnostics Market to 2027 – COVID-19 Impact and Regional Analysis and Forecast by Product and Services, Technology, Application, and End User,” is expected to reach US$ 38,759.6 million by 2027 from US$ 26,981.2 million in 2019. The market is estimated to grow at a CAGR of 4.7% from 2020 to 2027. The report provides trends prevailing in the North America In-vitro diagnostics market along with the drivers and restraints pertaining to the market growth. The increasing prevalence of chronic and infectious diseases, growing geriatric population and a rising demand for in-vitro diagnostics during covid-19 pandemic. However, the market is expected experiencing slow growth during the forecast period owing to the lack of healthcare infrastructure and reimbursement policies.

The outbreak of COVID-19 has offered significant growth opportunities for the in-vitro diagnostics market in the North American region. The US was likely adversely affected by the pandemic and faced significant mortalities due to SARS-CoV-2 virus infection. Hence, to detect the presence of infection among the people, there was a huge demand generated for in vitro diagnostics and rapid tests. The generated demand has offered positive growth for the in-vitro diagnostic market in the region. In addition, various companies have shifted their focus to molecular diagnostics and testing. Thus, there was an exponential shift in demand for RT-PCR procedures, assays, kits, and reagents, as these diagnostic technologies offer results in less time. Also, the companies operating in this particular segment (IVD) have generated profits.

The market for In-vitro diagnostics market is segmented into product and services, technology, application, and end user. Based on product and services, the market is segmented into reagents and kits, instruments, and software and services. In 2019, the instruments and kits segment accounted for the largest market share in the in-vitro diagnostics market. The growth of the instruments and kits segment is expected to grow due to increasing adoption of in-vitro diagnostics across the region. Moreover, increasing prevalence of chronic diseases coupled with growing awareness and availability of the product in considerable margins are projected to drive the growth of the instruments and kits segment during the forecast period.

F. HOFFMANN-LA ROCHE LTD., DANAHER, ABBOTT, SIEMENS AG, SYSMEX CORPORATION, THERMO FISHER SCIENTIFIC, INC., BD, BIOMERIEUX SA, BIO-RAD LABORATORIES, INC., and QIAGEN are among the leading companies in the North America In-vitro diagnostics market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2019, Roche launched a diagnostic tool named as VENTANA ROS1 a in vitro diagnostic ROS1 immunohistochemistry (IHC) assay. The test detects the presence of ROS1 protein in tissue and may be useful in identifying ROS1-positive cancer cases.

The report segments the North America In-Vitro Diagnostics market as follows:

By Product and Services

  • Instruments
  • Reagents & Kits
  • Software & Services

By Technology

  • Immunoassay/ Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation & Hemostasis
  • Hematology
  • Urinalysis
  • Others

By Application

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Others

By End User

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By Country

  • North America
    • US
    • Canada
    • Mexico
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: 


Download Free PDF Brochure